Apellis Pharmaceuticals, Inc. ( APLS) - Key Metrics
Stock symbol APLS is outdated, potentially delisted? Maybe it is available on other exchange?
APLS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.59 | -$0.47 | -$0.11 | -$0.11 |
| 2025Q3 | $3.64 | $1.71 | $0.86 | $0.86 |
| 2025Q2 | $1.42 | -$0.33 | $0.04 | $0.03 |
| 2025Q1 | $1.33 | -$0.74 | -$0.43 | -$0.43 |
APLS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -13.43 |
| 2025Q3 | ? | 3.31 |
| 2025Q2 | ? | -12.94 |
| 2025Q1 | ? | -7.44 |
APLS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.20% | ? |
| 2025Q4 | -0.44% | ? |
| 2025Q3 | 3.80% | ? |
| 2025Q2 | 0.20% | ? |
| 2025Q1 | -1.95% | ? |
APLS
Price: $41.03
52 week price:
Earnings Per Share: 1.07 USD
P/E Ratio: 38.34
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Ebitda: -11.6 millionMarket Capitalization: 5.3 billion